Mortality in ankylosing spondylitis according to treatment: comment on the article by Ben Shabat et al

被引：0

作者：

Li, Zhixiu ^{[1
,2
]}

Khan, Mohammad K. ^{[3
]}

Villiger, Peter M. ^{[4
]}

van der Linden, Sjef ^{[5
]}

Brown, Matthew A. ^{[6
]}

Khan, Muhammad A. ^{[7
]}

机构：

[1] Queensland Univ Technol, Brisbane, Qld, Australia

[2] Princess Alexandra Hosp, Brisbane, Qld, Australia

[3] Kent State Univ, Kent, OH 44242 USA

[4] Med Zentrum Monbijou, Bern, Switzerland

[5] Univ Maastricht, Maastricht, Netherlands

[6] Kings Coll London, Genom England, London, England

[7] Case Western Reserve Univ, Cleveland, OH 44106 USA

来源：

ARTHRITIS CARE & RESEARCH | 2022年 / 74卷 / 12期

关键词：

D O I：

10.1002/acr.24773

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2120 / 2121

页数：2

共 50 条

[21] The implications of biologic therapy in ankylosing spondylitis: comment on the articles by Brandt et al and Braun et al
Mascarenhas, R
Davis, M
Robertson, L
ARTHRITIS AND RHEUMATISM, 2004, 50 (07): : 2376 - 2377
[22] The difficulties in establishing a birth order or maternal age effect in ankylosing spondylitis: comment on the article by Baudoin et al - Reply
van der Horst-Bruinsma, IE
Bezemer, PD
Dijkmans, BAC
ARTHRITIS AND RHEUMATISM, 2002, 46 (02): : 564 - 564
[23] Increased risk of ankylosing spondylitis among first-born children: Comment on the article by Baudoin et al - Reply
van der Horst-Bruinsma, IE
Bezemer, PD
Dijkmans, BAC
ARTHRITIS AND RHEUMATISM, 2001, 44 (08): : 1965 - 1965
[24] Change of bone mineral density and treatment of ankylosing spondylitis. Comment to the article of Kang KY et al. "The change of bone mineral density according to treatment agents in patients with ankylosing spondylitis" Joint Bone Spine 2011;78:188-93
Wendling, Daniel
Prati, Clement
Toussirot, Eric
Dumoulin, Gilles
JOINT BONE SPINE, 2012, 79 (02) : 207 - 207
[25] The implications of biologic therapy in ankylosing spondylitis: comment on the articles by Brandt et al and Braun et al - Reply
Braun, J
Sieper, J
ARTHRITIS AND RHEUMATISM, 2004, 50 (07): : 2377 - 2378
[26] Low Rate of Progression to Ankylosing Spondylitis Among Patients With Presumed Nonradiographic Axial Spondyloarthritis: Comment on the Article by Wang et al
Braun, Juergen
Sieper, Joachim
ARTHRITIS & RHEUMATOLOGY, 2017, 69 (03) : 676 - 677
[27] Association of HLAaEuroB27 and its subtypes with ankylosing spondylitis and clinical manifestations of ankylosing spondylitis in different HLA-B27 subtypes: comment on the article by Lin et al.
Fallahi, Sasan
RHEUMATOLOGY INTERNATIONAL, 2017, 37 (10) : 1683 - 1683
[28] Low rate of progression to ankylosing spondylitis among patients with presumed nonradiographic axial spondyloarthritis: comment on the article by Wang et al Reply
Wang, Runsheng
Ward, Michael M.
ARTHRITIS & RHEUMATOLOGY, 2017, 69 (03) : 677 - 678
[29] The intestinal microbiome in ankylosing spondylitis: comment on the article by Rosenbaum and Davey
Highton, John
Stebbings, Simon
Jenks, Katey
ARTHRITIS AND RHEUMATISM, 2012, 64 (02): : 597 - 598
[30] What constitutes a mortality study? Comment on the article by Uramoto et al
Wallace, DJ
ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : 2021 - 2022

← 1 2 3 4 5 →